- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05236881
Development of an mHealth Tool (ANíMATE) to Assess Self-management, Self-care and Adherence in People With Obesity (ANíMATE)
This trial main purpose is to develop and test an mHealth app aimed at improving self-management, self-care and adherence of people with obesity.
The study population are type I or II obese people, aged more than 18 years old, with or without comorbidities, who have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and access to a scale for regular weight monitoring.
Control group will follow standard care protocol and patients in the intervention group will also be provided with the app. Follow-up will be done for 16 weeks. Both groups will attend 3 face-to-face visits (baseline, 2 and 4 months).
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Barcelona, Espagne, 08025
- Recrutement
- Hospital de la Santa Creu i Sant Pau
-
Contact:
- Cintia Gonzalez Blanco, MD, PhD
- Numéro de téléphone: +34610898918
- E-mail: cgonzalezb@santpau.cat
-
Chercheur principal:
- Cintia Gonzalez Blanco, MD, PhD
-
Sous-enquêteur:
- Gemma Cuixart Carruesco, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients over 18 years of age.
- People with BMI 30-39.9 kg/m2.
- Have a smartphone or tablet compatible with the app (Android version 9.0 or higher) and have sufficient capabilities to use it.
- Have access to a scale for regular weight monitoring.
Exclusion Criteria:
- Presence of serious major comorbidities: High blood pressure treated with > 3 drugs, diabetes mellitus treated with insulin, dyslipidemia treated with PCSK9 inhibitors, sleep apnea-hypopnea syndrome treated with CPAP, ischemic heart disease or stroke.
- Use of pharmacological treatment with influence on weight started in the 6 months prior to study entry.
- History of weight loss intervention (diet, exercise) in the 6 months prior to study entry.
- History of eating disorder.
- History of bariatric surgery.
- Use of any other app or treatment to lose weight in the 6 months prior to study entry.
- Pregnancy, short-term gestational desire or lactation.
- Any other disease or condition that may interfere with compliance with the protocol or completion of the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: ANíMATE mobile application
Standard care protocol (3 face-to-face visits: basal, 2 and 4 months) + ANíMATE mobile application
|
mHealth tool ANíMATE (Adherence, Nutrition, PhysIcal Activity, Motivation, medicAtion, Technology and Empowerment) allows the recording of data related to diet and exercise and feedback on behavior through an intelligent data analysis system.
|
Aucune intervention: Standard care
Standard care protocol (3 face-to-face visits: basal, 2 and 4 months)
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
%TWL at 4 months
Délai: 4 months
|
Percentage of total weight loss (%TWL) at 4 months
|
4 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
%TWL at 2 months
Délai: 2 months
|
Percentage of total weight loss (%TWL) at 2 months
|
2 months
|
%EWL at 2 and 4 months
Délai: 2 and 4 months
|
Percentage of excess weight loss (%EWL) at 2 and 4 months
|
2 and 4 months
|
BMI change at 2 and 4 months
Délai: Baseline, 2 and 4 months
|
Change in body mass index (BMI) (kg/m^2) from baseline to 2 and 4 months
|
Baseline, 2 and 4 months
|
Waist change at 2 and 4 months
Délai: Baseline, 2 and 4 months
|
Change in waist circumference (cm) from baseline to 2 and 4 months
|
Baseline, 2 and 4 months
|
Blood pressure change at 2 and 4 months
Délai: Baseline, 2 and 4 months
|
Change in systolic and diastolic blood pressure (mmhg) from baseline to 2 and 4 months
|
Baseline, 2 and 4 months
|
HbA1c change at 2 and 4 months
Délai: Baseline, 2 and 4 months
|
Change in HbA1c percent from baseline to 2 and 4 months
|
Baseline, 2 and 4 months
|
Mediterranean diet adherence change at 4 months
Délai: Baseline and 4 months
|
Change in mediterranean diet adherence questionnaire score (0*-14, *indicates worse questionnaire results) from baseline to 4 months
|
Baseline and 4 months
|
IPAQ change at 4 months
Délai: Baseline and 4 months
|
Change in International Physical Activity Questionnaire (IPAQ) score (cathegory results: low/inactive*, moderate or high, *indicates worse questionnaire results) from baseline to 4 months
|
Baseline and 4 months
|
ACTA change at 4 months
Délai: Baseline and 4 months
|
Change in attitudes towards change in eating disorders (ACTA) questionnaire score (0*-236, *indicates worse questionnaire results) from baseline to 4 months
|
Baseline and 4 months
|
Adherence to records
Délai: 2 and 4 months
|
Percentage of records (weight, diet) at 2 and 4 months
|
2 and 4 months
|
Adherence to recommendations
Délai: 2 and 4 months
|
Percentage of recommendations given by the medical team followed at next visit
|
2 and 4 months
|
Adherence to visits
Délai: 2 and 4 months
|
Percentage of face-to-face visits attended
|
2 and 4 months
|
Adherence to the app
Délai: 2 months after the end of the study
|
Percentage of patients who continue using the 2 months app after the end of the study
|
2 months after the end of the study
|
Quality of life change at 4 months
Délai: Baseline and 4 months
|
Change in Short-Form Health Survey SF-36 questionnaire score (0*-100, *indicates worse questionnaire results) from baseline to 4 months
|
Baseline and 4 months
|
Satisfaction with the app
Délai: 4 months
|
Satisfaction questionnaire in relation to the use of the app score (0*-20, *indicates worse questionnaire results) in the intervention group at the end of the study
|
4 months
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IIBSP-ANI-2020-10
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur ANíMATE mobile application
-
Sense A/SRetiréHypertension | En bonne santé | Hypotension
-
Ankara City Hospital BilkentComplétéDiabète de type 1Turquie
-
Aydin Adnan Menderes UniversityComplété
-
Centre Integre Universitaire de Sante et Services...RecrutementHypertension | Maladie rénale chronique | Pression artérielleCanada
-
University Medicine GreifswaldComplété